Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

BACKGROUND: The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model. METHODS: The propensity score in each study was defined as the probability of an individual patient b...

Full description

Saved in:
Bibliographic Details
Published in:BMC Neurol
Main Authors: Cutter, Gary R., Knappertz, Volker, Sasson, Nissim, Ladkani, David
Format: Artigo
Language:Inglês
Published: BioMed Central 2016
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027083/
https://ncbi.nlm.nih.gov/pubmed/27639853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-016-0702-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items